Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$9.65
-8.1%
$10.97
$8.80
$32.71
$467.90M3.291.14 million shs755,376 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.48
+2.1%
$9.86
$8.12
$18.23
$387.27M0.54339,366 shs569,665 shs
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$0.75
+0.9%
$0.51
$0.38
$3.03
$118.68M2.111.73 million shs1.16 million shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.81
+1.4%
$16.78
$14.42
$23.70
$451.29M0.99199,698 shs171,008 shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
0.00%+2.94%+7.25%-19.72%-26.93%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
0.00%+8.29%+14.11%+19.96%-3.19%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
0.00%+17.35%+60.85%+80.27%-50.46%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.00%+16.67%+9.74%+5.53%-20.87%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$9.65
-8.1%
$10.97
$8.80
$32.71
$467.90M3.291.14 million shs755,376 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.48
+2.1%
$9.86
$8.12
$18.23
$387.27M0.54339,366 shs569,665 shs
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$0.75
+0.9%
$0.51
$0.38
$3.03
$118.68M2.111.73 million shs1.16 million shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.81
+1.4%
$16.78
$14.42
$23.70
$451.29M0.99199,698 shs171,008 shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
0.00%+2.94%+7.25%-19.72%-26.93%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
0.00%+8.29%+14.11%+19.96%-3.19%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
0.00%+17.35%+60.85%+80.27%-50.46%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.00%+16.67%+9.74%+5.53%-20.87%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2.67
Moderate Buy$22.00127.98% Upside
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
2.67
Moderate Buy$22.5095.99% Upside
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
2.40
Hold$5.40615.52% Upside
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.82
Moderate Buy$24.4437.25% Upside

Current Analyst Ratings Breakdown

Latest GUTS, BBNX, KIDS, and DCTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$17.00
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingBuy$24.00
4/24/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$25.00
4/24/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Reiterated RatingBuy$8.00
4/22/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Lower Price TargetOutperform$25.00 ➝ $24.00
4/22/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Lower Price TargetBuy$22.00 ➝ $20.00
4/21/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
DowngradeSell (D-)Sell (E+)
4/21/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingSell (E+)
4/15/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Lower Price TargetBuy$25.00 ➝ $18.00
4/9/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Lower Price TargetBuy$23.00 ➝ $20.00
3/27/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Reiterated RatingSell (D-)
(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$100.25M4.29N/AN/A$6.09 per share1.58
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$85.23M4.64$0.05 per share215.02$3.15 per share3.64
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$90K1,330.37N/AN/A$0.07 per share10.78
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$236.35M1.94$0.17 per share105.66$13.19 per share1.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$73.20M-$1.51N/AN/AN/A-60.27%-23.00%-20.55%N/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.70M$0.011,148.00114.80N/A0.62%0.51%0.46%N/A
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$140.95M-$1.84N/AN/AN/AN/A-2,896.77%-104.24%5/12/2026 (Estimated)
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$39.65M-$1.68N/AN/AN/A-16.31%-7.01%-4.86%N/A

Latest GUTS, BBNX, KIDS, and DCTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2026Q1 2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.17N/AN/AN/AN/AN/A
5/7/2026Q1 2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.0971-$0.03+$0.0671-$0.03$23.51 million$24.99 million
4/30/2026Q1 2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.4552-$0.42+$0.0352-$0.45$58.29 million$59.36 million
4/21/2026Q1 2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.53-$0.49+$0.04-$0.49N/A$27.63 million
3/24/2026Q4 2025
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.19$0.15+$0.34-$0.07N/AN/A
2/26/2026Q4 2025
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.06-$0.05+$0.01-$0.05$20.35 million$20.73 million
2/26/2026Q4 2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.37-$0.26+$0.11-$0.43$61.27 million$61.61 million
2/17/2026Q4 2025
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.42-$0.30+$0.12-$0.30N/A$32.12 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
10.69
9.67
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
10.92
9.98
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
3.23
4.78
4.78
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.29
5.21
2.65

Institutional Ownership

CompanyInstitutional Ownership
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%

Insider Ownership

CompanyInsider Ownership
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
5.30%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
19.36%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
8.52%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
32.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
29444.56 million42.20 millionN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
6034.46 million27.79 millionOptionable
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
102158.65 million145.13 millionN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
20025.68 million17.29 millionOptionable

Recent News About These Companies

OrthoPediatrics (KIDS) Q1 2026 Earnings Transcript
OrthoPediatrics Q1 Earnings Call Highlights
OrthoPediatrics Earnings Call Flags Profitable Turn

New MarketBeat Followers Over Time

Media Sentiment Over Time

Beta Bionics stock logo

Beta Bionics NASDAQ:BBNX

$9.65 -0.85 (-8.10%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$9.64 -0.02 (-0.16%)
As of 05/8/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Delcath Systems stock logo

Delcath Systems NASDAQ:DCTH

$11.48 +0.24 (+2.14%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$11.48 +0.00 (+0.04%)
As of 05/8/2026 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Fractyl Health stock logo

Fractyl Health NASDAQ:GUTS

$0.75 +0.01 (+0.88%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$0.74 -0.01 (-1.95%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$17.81 +0.24 (+1.37%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$17.81 0.00 (-0.01%)
As of 05/8/2026 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.